Ranked #7,108 of 8,699 institutional investors
Andera Partners
Paris, I0
$149M
US stock portfolio at live prices · today +$1.5M (+1.01%)
Market closed. Prices as of Nov 20, 6:11 AM ET
- Value at quarter end (Q3 2026)
- $176M
- Change from Q2 2026
- −$30.8M (−14.91%)
- Positions
- 5 · 0 new, 1 sold out
- Filed
- Oct 16, 2026
Not counted in the ranking: none$77.9M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesAVLN 17.9%MLYS 15.1%IVA 8.41%AGMB 5.80%EVMN 0.47%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| AVLN Avalyn Pharma Inc. | 929,824 | $26.7M | 17.9% | Unchanged |
| MLYS Mineralys Therapeutics, Inc. | 1,591,917 | $22.5M | 15.1% | Unchanged |
| IVA Inventiva S.A. | 3,633,181 | $12.5M | 8.41% | Unchanged |
| AGMB AgomAb Therapeutics NV | 1,538,702 | $8.6M | 5.80% | Unchanged |
| EVMN Evommune Inc | 97,362 | $705K | 0.47% | Reduced −93% |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| ABVX ABIVAX Société Anonyme | 78,125 | $6.3M |